Table 3.
Prediction of outcomes with SUVmax, TMTV and TLG
| Progression-free survival | Overall survival | |||||
|---|---|---|---|---|---|---|
| SUVmax | TMTV | TLG | SUVmax | TMTV | TLG | |
| Se (%) | 83.0 | 72.3 | 74.5 | 83.0 | 73.9 | 76.1 |
| Sp (%) | 37.8 | 81.1 | 62.2 | 39.5 | 81.6 | 63.2 |
| Acc (%) | 63.1 | 76.2 | 69.0 | 64.3 | 77.4 | 70.2 |
| PPV (%) | 62.9 | 82.9 | 71.4 | 62.9 | 82.9 | 71.4 |
| NPV (%) | 63.6 | 69.8 | 65.7 | 65.2 | 72.1 | 68.6 |
Se sensitivity, Sp specificity, Acc accuracy, PPV positive predictive value, NPV negative predictive value, SUVmax maximum standardized uptake value, TMTV total metabolic tumor volume, TLG total lesion glycolysis